Zoekresultaten
Alle resultaten weergeven
Home Home Home
Home
Reels
Groepen
Pagina
Kijk verder.....
Groepen Pagina Events Blogs Funding Offers Jobs Forums Movies
Registreer
Log in Creëer je account
Theme Switcher
Day Mode
Bedrijvengids
Gebruikers
Berichten
Pagina
Groepen
Events
  • OddStatus7515 Chu @OddStatus7515 toegevoegd een foto
    2025-12-08 11:07:04 ·
    Why do people act like plane seats are first-come first-steal?
    Why do people act like plane seats are first-come first-steal?
    Like
    Love
    Wow
    3
    · 0 Reacties ·0 aandelen ·86K Views ·0 voorbeeld
    Please log in to like, share and comment!
  • UsefulHuckleberry42 Chử @UsefulHuckleberry42 toegevoegd een foto
    2025-12-08 11:13:04 ·
    POV: you just gave a man a compliment
    POV: you just gave a man a compliment
    Like
    Love
    Wow
    3
    · 0 Reacties ·0 aandelen ·86K Views ·0 voorbeeld
    Please log in to like, share and comment!
  • StupidGermanMoney Bành @StupidGermanMoney toegevoegd een foto
    2025-12-08 11:14:04 ·
    ich_iel
    ich_iel
    Like
    Love
    Wow
    3
    · 0 Reacties ·0 aandelen ·57K Views ·0 voorbeeld
    Please log in to like, share and comment!
  • ladyprincess7946 Dã @ladyprincess7946 toegevoegd een foto
    2025-12-08 11:21:05 ·
    We are coocked
    We are coocked
    Like
    Love
    Wow
    3
    · 0 Reacties ·0 aandelen ·86K Views ·0 voorbeeld
    Please log in to like, share and comment!
  • RealMarzipan7347 Chử @RealMarzipan7347 toegevoegd een foto
    2025-12-08 11:23:04 ·
    He's got a point...
    He's got a point...
    Like
    Love
    Wow
    3
    · 0 Reacties ·0 aandelen ·83K Views ·0 voorbeeld
    Please log in to like, share and comment!
  • Saurav Kumar @kumarkk toegevoegd een foto
    2025-12-08 11:24:24 ·
    Global Afamelanotide Market (2024–2032): USD 136.27M to USD 258.01M Growth at 9.1% CAGR
    Global Afamelanotide Market is projected to grow from USD 136.27 million in 2024 to USD 258.01 million by 2032, registering a strong CAGR of 9.1%. Afamelanotide (SCENESSE®), the first approved treatment for EPP, enhances melanin production to improve sunlight tolerance in patients with severe phototoxic disorders. Rising awareness of rare diseases, expanding clinical trials in vitiligo and photodermatoses, and broader regulatory support are fueling market demand globally.
    Global Afamelanotide Market (2024–2032): USD 136.27M to USD 258.01M Growth at 9.1% CAGR Global Afamelanotide Market is projected to grow from USD 136.27 million in 2024 to USD 258.01 million by 2032, registering a strong CAGR of 9.1%. Afamelanotide (SCENESSE®), the first approved treatment for EPP, enhances melanin production to improve sunlight tolerance in patients with severe phototoxic disorders. Rising awareness of rare diseases, expanding clinical trials in vitiligo and photodermatoses, and broader regulatory support are fueling market demand globally.
    0 Reacties ·0 aandelen ·223 Views ·0 voorbeeld
    Please log in to like, share and comment!
  • ohheysarahjay Friesen @ohheysarahjay toegevoegd een foto
    2025-12-08 11:25:04 ·
    We had some surprisingly friendly guests visiting our camp site
    We had some surprisingly friendly guests visiting our camp site
    Like
    Love
    Wow
    3
    · 0 Reacties ·0 aandelen ·14K Views ·0 voorbeeld
    Please log in to like, share and comment!
  • CarelessEast45 Châu @CarelessEast45 toegevoegd een foto
    2025-12-08 11:32:04 ·
    Hell nah!
    Hell nah!
    Like
    Love
    Wow
    3
    · 0 Reacties ·0 aandelen ·86K Views ·0 voorbeeld
    Please log in to like, share and comment!
  • FunPie9594 Lý @FunPie9594 toegevoegd een foto
    2025-12-08 11:33:04 ·
    Features no one asked for
    Features no one asked for
    Like
    Love
    Wow
    3
    · 0 Reacties ·0 aandelen ·82K Views ·0 voorbeeld
    Please log in to like, share and comment!
  • Display (145513-145521 of 145635)
  • «
  • Vorige
  • 16167
  • 16168
  • 16169
  • 16170
  • 16171
  • Volgende stap
  • »
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
© 2025 Home
Dutch
Language English VN French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek Arabic
About Voorwaarden Privacy Contact Us Bedrijvengids